AU Patent

AU777915B2 — Use of macrolide compounds for the treatment of dry eye

Assigned to Sucampo GmbH · Expires 2004-11-04 · 22y expired

What this patent protects

Patent listed against Sandimmune.

Drugs covered by this patent

Patent Metadata

Patent number
AU777915B2
Jurisdiction
AU
Classification
—
Expires
2004-11-04
Drug substance claim
No
Drug product claim
No
Assignee
Sucampo GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.